It is well recognized that hypertensive target organ damage (TOD) and cardiovascular events are associated with elevated blood pressure (BP), as determined from the average of multiple BP readings (mean BP). 1 The extent to which BP fluctuates over time, expressed as BP variability (BPV), has been suggested to offer incremental prognostic value, over and above mean BP levels. 2 However, the independent value of BPV is not yet established and results are conflicting between the different ways to assess BPV such as reading-to-reading, day-to-day, or visit-to-visit BPV. [3] [4] [5] [6] [7] [8] This lack of clarity with respect to the clinical significance of different BPV assessment methods may be related to the different pathophysiological pathways reflected by each type of BPV. 9 Importantly, there has never been a longitudinal study to examine the relation of BPV with TOD (for example, cardiac structure or aortic stiffness) utilizing more than one way to assess BPV in the same population. Therefore, a cause and effect relationship between BPV and TOD has not yet been clearly determined. On the contrary, the prognostic relevance of mean BP level as derived from clinic, 24-hour ambulatory or home BP to TOD is well known. 10, 11 This study aimed to investigate the relationship between the changes in mean BP levels and BPV indices as derived from reading-toreading, day-to-day, as well as visit-to-visit BP monitoring, on changes in TOD (assessed by left ventricular mass index (LVMI) and aortic pulse wave velocity (aPWV)) in patients with uncomplicated hypertension followed over 12 months. We hypothesized that changes in BPV will be associated with changes in TOD indices and that these associations will be independent of mean BP levels.
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Study protocol
Participants attended the study sites on 5 occasions over 12 months, at 3-month intervals. Clinic and home BP was measured at all 5 occasions, and 24-hour ambulatory BP, LVMI, and aPWV measurements were performed at baseline and at the 12-month visit. Complete data for all BP variables, as well as LVMI and aPWV measures were available on 267 and 250 participants, respectively. Antihypertensive therapy was assessed at all 5 visits, and recommendations regarding medication titration were provided to each patient's doctor. Extensive details on the titration recommendations have been published elsewhere. 12 
Target organ damage
Real-time 3D imaging was undertaken to measure LVM using a matrix array transducer. This has greater accuracy and lower test-retest variation, compared to other measurement techniques. 13 LVMI was derived after indexing LVM to height 2.7 according to guidelines. 13, 14 Aortic stiffness was assessed using tonometry readings of carotid to femoral pulse wave velocity, according to guidelines 15 with the patient in a supine position (SphygmoCor 8.0; AtCor Medical, Sydney, NSW).
Clinic BP
The average of 2 BP measurements taken 1 minute apart was calculated after 10 minutes of rest, which results in lower average BP that is more clinically relevant than averaging BP after 5 minutes of rest. 16 We used a validated 17 automatic device for this purpose (Omron HEM-907; OMRON Europe B.V. (OMCE), Hoofddorp, The Netherlands). Measurements were recorded using an appropriate size of cuff, with the patients' arm supported at the height of the heart, back supported, and feet flat on the floor as per recommendations. 1 
7-day home BP
A validated 18 oscillometric device (UA-767, A&D Mercury; A&D Medical, Thebarton, South Australia, Australia) was given to participants to record home BP. Participants were instructed to measure their BP twice after 5 minutes of rest but only record the second reading. They were also instructed to take BP in the morning (between 06:00 and 10:00), in the evening (between 18:00 and 22:00), and at midday if possible.
24-hour ambulatory BP
A validated 19 BP device (TM-2430, A&D Mercury; A&D Medical) was used to take BP measurements every 30 minutes during the day and every hour during the night. The daytime period was defined as the time between 06:00 to 22:00 and the night-time period as the interval between 22:00 to 06:00. Participants were advised to maintain routine daily activities but to avoid strenuous physical activities. Data were included for analysis if there were more than 10 BP measurements and if >80% of readings were valid. Measurements with an error code or a pulse pressure <20 mm Hg were excluded from the analysis.
BPV
Systolic BPV (SBPV) and diastolic BPV calculated as the SD around the mean, as well as the coefficient of variation (coefficient of variation; (SD/mean) × 100), using the corresponding mean BP level. Reading-to-reading BPV derived from the 24-hour ambulatory BP monitoring and assessed separately for 24-hour, daytime and night-time periods. Day-to-day BPV was calculated from the 7-day home BP monitoring using all the available measurements rather than the average of each day in order to provide a greater number of BPs to allow for a better representation of BP fluctuations. Visit-to-visit BPV derived from clinic BP measured at 5 visits. The results are presented using the coefficient of variation as it takes into account the relationship between mean BP levels and BPV.
Antihypertensive medications quantity
The daily defined dose (DDD) of medications was calculated as per World Health Organization standards and was recorded at all 5 visits; compliance was assessed by the study nurse viewing each participant's medication packet(s). Participants were categorized into groups based on the change in DDD over 12-months follow-up: (i) those who had an increase, (ii) those who had a decrease, and (iii) those who had no change, according to tertiles of the change in DDD. This enabled quantification of the change in DDD as well as the direction of the change (decrease or increase) over time. In this study, participants were randomized to have changes in medication guided by either usual care (based on clinic, 7-day and 24-hour ambulatory BP) or additionally using central BP measures. 12 
Statistical analysis
The change in the measured variables over the 12-month follow-up was calculated as the difference between baseline and 12 months. The relationships between the changes in LVMI (ΔLVMI) and aPWV (ΔaPWV) and the changes in mean BP levels or BPV measures were assessed using linear regression analysis, which was repeated after adjusting for baseline age, sex, and body mass index. In order to assess if BPV indices were independently predicting changes in the outcomes, multivariable models were further adjusted for the changes in mean BP levels. Models were also adjusted for the change in DDD. Further sensitivity analyses are detailed in Supplementary Appendix. Student's t-test was used to compare changes in mean BP and BPV variables between groups. A P <0.05 was considered statistically significant. Statistical analyses were performed using Stata 12.1 (StataCorp, College Station, TX). Table 1 shows the baseline demographic and clinical characteristics of the study participants. A small percentage of patients had type 2 diabetes (8%) while almost half of the study population were either current or former smokers. Mean LVMI was 31.28 (5.54) g/m 2.7 and aPWV was 9.41 (2.14) m/s at baseline and values were not changed at 12 months on average; 31.30 (5.50) g/m 2.7 and 9.35 (2.02) m/s, respectively. At baseline, the strongest predictor of LVMI was mean 24-hour ambulatory SBP (P = 0.03) and clinic SBP for aPWV (P < 0.001). None of the baseline BPV measures were correlated with either LVMI or aPWV (P ≥ 0.08 for all) while further adjustment for mean 24-hour ambulatory BP levels did not change these associations. Table 2 shows the comparison of the change in mean BP levels between the upper and the lower quartile of ΔLVMI. All mean 24-hour ambulatory BPs indices, except mean night-time DBP, were significantly increased among participants who had an increase in LVMI compared with those who had a decrease in LVMI. None of the changes in clinic or 7-day home BP were significantly different between the groups. In univariable analysis, ΔLVMI was positively associated with changes in mean 24-hour ambulatory, daytime and night-time SBP and remained significant in multivariable analyses adjusted for age, sex, and body mass index (Table 3) . No associations were observed between ΔLVMI and visit-to-visit mean BP ( Table 3) . The above results remained unchanged after adjustment for changes in DDD.
RESULTS

Participant characteristics
Associations of mean BP variables with ΔLVMI
Associations of BPV variables with ΔLVMI
24-hour ambulatory and daytime SBPV were paradoxically decreased among participants who had an increase in LVMI compared with those who had a decrease in LVMI ( Table 2) . None of the changes in BPV measures were significantly different between the groups. Furthermore, a paradoxical, negative and independent association was observed between ΔLVMI, and the changes in 24-hour SBPV, but inclusion of the changes in mean night-time ambulatory SBP in the model, rendered the relationship nonsignificant (P = 0.14). None of the visit-to-visit BPV indices were associated with ΔLVMI (Table 3) . Results were unchanged after further adjustment for the changes in DDD. Table 4 shows the comparison of the change in mean BP levels and BPV indices between the upper and the lower quartile of ΔaPWV. Mean 24-hour ambulatory, daytime SBP and DBP, and mean clinic SBP and DBP were significantly increased among participants who had an increase in aPWV compared with those who had a decrease in aPWV. None of the 7-day home BPs were significantly different between the groups. In univariable analysis, ΔaPWV was positively associated with changes in mean 24-hour ambulatory, daytime and night-time SBP; clinic SBP; and changes in mean 24-hour ambulatory, daytime, night-time, and clinic DBP ( Table 3 ). All of these associations remained significant after adjusting for baseline age, sex, and body mass index (Table 3) ; however, the associations between changes in mean clinic DBP indices and ΔaPWV were not significant after adjusting for changes in mean 24-hour ambulatory SBP or changes in mean clinic SBP (P > 0.05 for all). Changes in mean visit-to-visit SBP and DBP were not associated with ΔaPWV (Table 3) . Results were unchanged after further adjustment for the changes in DDD. 
Associations of mean BP variables with ΔaPWV
Associations of BPV variables with ΔaPWV
There were no significant differences in the change in reading-to-reading or day-to-day BPV indices between the upper and the lower quartile of the aPWV changes with the exception of the night-time SBPV, which was increased among participants who had an increase in aPWV (Table 4) . None of the changes in BPV indices, neither reading-toreading nor day-to-day nor visit-to-visit BPV indices, were associated with ΔaPWV (Table 3) .
Changes in DDD and mean BP levels and BPV Figure 1 shows the comparison of the changes in mean BP levels and BPV between participants who had an increase and participants who had a decrease in DDD over time. As expected, for those participants who had an increase in DDD there was a corresponding decrease in all mean systolic and diastolic BP (DBP) measures, while an increase in all mean BP levels measures was observed for those who had a decrease in DDD (P < 0.05 for all). On the contrary, no significant differences were observed between groups with increased or decreased DDD in terms of BPV indices, with the exception of the day-to-day SBPV, which was paradoxically increased for those who had an increase in DDD (P = 0.03).
Sensitivity analysis
Comparable results were observed for BPV indices calculated using the SD instead of the coefficient of variation. Results were unchanged for the reading-to-reading BPV indices after exclusion of the periods from 20:00 to 22:00 and 06:00 to 08:00 and for visit-to-visit BPV when analysis was repeated using the 7-day home BP instead of the clinic BP measures. Comparable results were also observed when dayto-day BPV was assessed separately for morning, midday, or evening measurements.
DISCUSSION
To our knowledge, this is the first reported follow-up study that has investigated the concept that the changes in TOD over time, as determined from cardiac structure and aortic stiffness, may not only depend on the changes in the magnitude of mean BP levels but also on the changes in the magnitude of BP fluctuations. Importantly, this is also the first study to investigate the effect on TOD from changes in BPV using clinic as well as out-of-office BP measures. The main findings were: (i) none of the changes in BPV were associated with ΔLVMI or ΔaPWV independent of the mean BP levels and (ii) only the changes in mean BP levels were related to the changes in TOD. Additionally, antihypertensive treatment titration had a clear and expected impact only on the changes in mean BP levels (i.e., decreased mean BP with increased DDD and vice versa) but with variable and sometimes paradoxical responses on BPV (Figure 1 ). These findings suggest that, at least from the point of view of predicting changes in TOD or effects of medications, BPV does not provide additional clinical information over and above mean BP levels in participants with uncomplicated hypertension. Previous cross-sectional studies have also reported a lack of significant associations between reading-to-reading or day-to-day BPV measures and LVMI in hypertensive patients. [20] [21] [22] [23] [24] Interestingly, one of the most cited works on BPV, in which patients were followed for up to 7.4 years with BP monitored invasively at baseline, reported a positive association between ΔLVMI and baseline reading-to-reading BPV. 25 However, the sample size of that population was small (n = 73) and was limited due to the lack of a follow-up assessment of BPV. A recent follow-up study also reported no Abbreviations: ΔaPWV, change in aortic pulse wave velocity; BP, blood pressure; BPV, blood pressure variability; ΔLVMI, change in left ventricular mass index.
a Adjusted for baseline age, sex, and body mass index. b Beta coefficient (95% confidence interval) (all such values). *P < 0.05, **P < 0.01, ***P < 0.001. Downloaded from https://academic.oup.com/ajh/article-abstract/29/9/1046/2622258 by guest on 27 January 2019 association between left ventricular hypertrophy (LVH) and long-term BPV; however, LVH was defined by electrocardiogram (a less sensitive method than echocardiography). 26 Other, cross-sectional studies [27] [28] [29] [30] [31] have found significant associations between reading-to-reading BPV and LVMI, independent of the mean BP levels. It is worth noting though that these studies have used SD to quantify BPV, which could have affected the results as even small degrees of multicollinearity, resulting from the well-known relationship between mean BP level and BPV, could affect the coefficients of the individual predictors in a model. Moreover, we are unaware of data available on visit-to-visit BPV with only one crosssectional study reporting a lack of significant associations between day-to-day BPV and LVMI. 24 Lastly, although large artery stiffness has been suggested to affect BPV, 9, 32 this is the first study that has investigated whether ΔaPWV was associated with changes in various BPV measures. Changes in BPV did not contribute in ΔaPWV, and our analyses clearly support the dependence of aPWV on mean BP levels, as is well known. 11 These findings are in line with recent crosssectional studies reporting no associations between readingto-reading BPV 33 and day-to-day BPV, 24 although Wei et al.
found a significant association between reading-to-reading BPV and aPWV in untreated hypertensive patients, 24 and Webb et al. reported a significant association between dayto-day BPV and aPWV in patients with transient ischemic attack or minor stroke. 33 Additionally, Song et al. found that visit-to-visit BPV was associated with ΔaPWV in hypertensive patients, independent of the mean visit-to-visit BP levels, 34 but this study did not adjust for changes in mean BP levels over the follow-up period, something that could attenuate the association observed. Lastly, carotid intima-media thickness, a marker of atherosclerosis, was not associated with visit-to-visit BPV in mild-to-moderate hypertensive patients followed for 4 years. 35 In vivo evidence suggests that an augmented BPV could cause a decrease in arterial distensibility and lead to aortic damage that could trigger LVH. 36 Similarly, it has been proposed that the mechanical stimuli resulting from an increased BPV could trigger the release of growth factors through the stimulation of mechanosensitive pathways that involve the local renin-angiotensin system and thus cause LVH. 37 Furthermore, increased BPV caused by an increased number of low BP episodes could deregulate cellular Data presented as mean (SD). A decrease or increase in aortic pulse wave velocity (aPWV) was defined as changes in aPWV within the lower (a decrease greater than or equal to 0.9m/s) or upper (an increase greater than or equal to 1m/s) quartiles of the change in aPWV over 12 months. Abbreviations: aPWV, aortic pulse wave velocity; BP, blood pressure; BPV, blood pressure variability.
Downloaded from https://academic.oup.com/ajh/article-abstract/29/9/1046/2622258 by guest on 27 January 2019 metabolism leading to hypoperfusion and eventually LVH. Indeed, many authors have supported the notion that BPV may have some predictive value in humans in relation to TOD, but this could be modified by the level of cardiovascular risk. 35, 38 In this current study population of patients with uncomplicated hypertension and a relative healthy vasculature in terms of aortic stiffness (baseline aPWV < 10 m/s), 1 low prevalence of diabetes (<10%), and without conditions such as severe LVH or preexisting coronary artery disease or renal disease, it seems that the susceptibility of the heart and large elastic arteries to BPV-related damage is low, at least within the timeframe of this study. The strengths of this study include the follow-up design that allowed the assessment of the relationship between the changes in the outcomes and the changes in BPV measures, as well as the variety of BPV types that were assessed in the same population and the concurrent assessment of the change in DDD. On the other hand, the analysis relating to reading-to-reading BPV may be limited as the time intervals between readings were greater than 20 minutes and therefore longer than has previously been recommended. 39 However, cross-sectional studies that have used time intervals less than 15 minutes have also reported no significant associations between BPV and LVMI. 20, 24 Additionally, the results of the analysis on the change in DDD may be limited by the lack of a subanalysis on medication class as different classes may have different effects on BPV. 40 However, an analysis regarding different antihypertensive medication classes was not possible due to the lack of statistical power. Lastly, the follow-up period might not have been adequate to investigate structural changes in LVMI and aPWV, and this may also help to explain the weak associations observed between the changes in mean BP levels and ΔLVMI.
This study provides evidence that changes in reading-toreading, day-to-day, as well as visit-to-visit BPV do not contribute substantially to ΔLVMI or ΔaPWV and thus may not offer any incremental prognostic value over and above mean BP levels in a population with uncomplicated hypertension. This is in agreement with previous suggestions that BPV may not have a predictive value in populations with low to moderate cardiovascular risk. Additionally, this study shows that when accounting for the change in antihypertensive dose, BPV may be a phenomenon which, coupled with the need to keep mean BP levels controlled, may not be an easily treatable target by common antihypertensive treatment. In conclusion, the main message of this study is that it would seem reasonable for clinicians to remain focussed on mean BP levels when tailoring hypertension management decisions rather than BPV in patients not subject to cardiovascular risk factors beyond uncomplicated hypertension.
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